{"title":"Pregnancy after fertility preservation and multimodal therapy including intensity-modulated radiotherapy for recurrent vulvar cancer: A case report.","authors":"Kosuke Murakami, Kiko Yamamoto, Takuya Uehara, Yukinori Matsuo, Noriomi Matsumura","doi":"10.1007/s13691-026-00855-5","DOIUrl":null,"url":null,"abstract":"<p><p>Advanced or recurrent vulvar cancer in women of reproductive age is extremely rare, and the effects of radiotherapy (RT) on uterine and ovarian function in such cases remain poorly understood. Here, we report the case of a 36-year-old woman with recurrent vulvar cancer after initial surgery. She strongly desired fertility preservation, so before undergoing resection of the recurrent lesion and inguinal lymphadenectomy, she underwent ovarian stimulation using a random-start progestin-primed ovarian stimulation (PPOS) protocol, and embryos were cryopreserved. Because of the high risk of recurrence, the patient underwent adjuvant intensity-modulated radiotherapy (IMRT) postoperatively. Three months after irradiation, ovarian function was lost; however, endometrial regrowth and withdrawal bleeding were observed with oral administration of norgestrel and ethinylestradiol. Despite significant vaginal and cervical atrophy, frozen-thawed embryo transfer was successfully performed in a hormone replacement cycle. Pregnancy was achieved with the second blastocyst transfer. Unfortunately, the patient subsequently developed acute myeloid leukemia, and continuation of the pregnancy was no longer feasible. This case suggests that IMRT may minimize scatter radiation to the uterine cavity, allowing for partial preservation of uterine function. Even in cases of advanced or recurrent vulvar cancer, fertility preservation strategies should be considered when appropriate.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"15 2","pages":"278-283"},"PeriodicalIF":0.5000,"publicationDate":"2026-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13038794/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Cancer Conference Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s13691-026-00855-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/4/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Advanced or recurrent vulvar cancer in women of reproductive age is extremely rare, and the effects of radiotherapy (RT) on uterine and ovarian function in such cases remain poorly understood. Here, we report the case of a 36-year-old woman with recurrent vulvar cancer after initial surgery. She strongly desired fertility preservation, so before undergoing resection of the recurrent lesion and inguinal lymphadenectomy, she underwent ovarian stimulation using a random-start progestin-primed ovarian stimulation (PPOS) protocol, and embryos were cryopreserved. Because of the high risk of recurrence, the patient underwent adjuvant intensity-modulated radiotherapy (IMRT) postoperatively. Three months after irradiation, ovarian function was lost; however, endometrial regrowth and withdrawal bleeding were observed with oral administration of norgestrel and ethinylestradiol. Despite significant vaginal and cervical atrophy, frozen-thawed embryo transfer was successfully performed in a hormone replacement cycle. Pregnancy was achieved with the second blastocyst transfer. Unfortunately, the patient subsequently developed acute myeloid leukemia, and continuation of the pregnancy was no longer feasible. This case suggests that IMRT may minimize scatter radiation to the uterine cavity, allowing for partial preservation of uterine function. Even in cases of advanced or recurrent vulvar cancer, fertility preservation strategies should be considered when appropriate.
期刊介绍:
This online-only journal publishes original case reports on all types of cancer. In particular, we welcome not only case reports of educational value in the diagnosis and treatment of cancers, but also reports on molecularly analyzed cancer cases, including gene mutations, gene fusions, gene expression, and changes in copy number, regardless of their known clinical significance. Assessing the molecular analysis of a tumor usually requires a “cancer conference” in which experts from various fields discuss it. Even if the authors and their respective “cancer conference” were unable to determine the clinical significance of molecular changes at the time of submission and publication, their data may provide evidence that will help the scientific community develop precision medicine solutions in the future. We welcome case reports with reviews of the literature on similar cases, as they are more useful and valuable to readers than are reports of rare cases. International Cancer Conference Journal is the official publication of the Japan Society of Clinical Oncology (JSCO).
- Presents an online-only collection of original case reports on all types of cancer
- In particular, welcomes molecularly analyzed cancer cases
- The Official Publication of the Japan Society of Clinical Oncology (JSCO)